LINCOLN PHARMACEUTICALS
Back to Cashflow Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹7.67 Cr | ₹0.70 Cr | ₹-1.88 Cr | ₹-4.50 Cr | ₹-0.70 Cr |
What is the latest Net Cash Inflow / Outflow ratio of LINCOLN PHARMACEUTICALS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹7.67 Cr |
| Mar2024 | ₹0.70 Cr |
| Mar2023 | ₹-1.88 Cr |
| Mar2022 | ₹-4.50 Cr |
| Mar2021 | ₹-0.70 Cr |
How is Net Cash Inflow / Outflow of LINCOLN PHARMACEUTICALS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹7.67 Cr | 1,003.17 | |
| Mar2024 | ₹0.70 Cr | Positive | |
| Mar2023 | ₹-1.88 Cr | Negative | |
| Mar2022 | ₹-4.50 Cr | Negative | |
| Mar2021 | ₹-0.70 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,218.7 Cr | 1.5% | -4% | 7.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -1.5% | 2.5% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹221,666.0 Cr | 7.4% | 22.2% | 26.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,108.0 Cr | 3.1% | 4.3% | 38.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.6% | -1.4% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,990.9 Cr | 1.5% | -15.2% | -9.1% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 1.5% |
-4% |
7.3% |
| SENSEX | 1.2% |
0.4% |
-2.9% |
You may also like the below Video Courses